Title for MeetingAbstracts
Alphabetical listing of titles
Antibodies in human sera to highly conserved epitopes in the V1/V2 domain of gp120 that mediate potent neutralization of macrophagetropic HIV-1 isolates.
Antibodies induced by Candida albicans surface mannans and monoclonal antibody B6.1 specific for the mannans help mice resist Candida vaginitis.
Antibodies reactive with C. neoformans capsular polysaccharide are found in both HIV+ and HIV- children.
Antibodies response against V3 loops synthetic peptides in cuban B subtype patients.
Antibodies to a carboxy terminal fusionprotein (CTF) of HIV gp41: longitudinal determinations in 12 patients.
Antibodies to a carboxy terminal fusionprotein (CTF) of HIV GP41: relation to clinical and immunological findings.
Antibodies to adhesion molecules and V3 act in synergy to neutralize HIV-1 primary isolates.
Antibodies to amino acid 603-622 of SIV transmembrane glycoprotein apparently enhance SIV infection in rhesus macaques.
Antibodies to Butyrate inducible antigens of Kaposi's sarcoma-associated herpesvirus (KSHV) in (HIV-1) infected patients.
Antibodies to CCR-5 receptors, and beta chemokines, generated by xenogeneic immunization, in the prevention of SIV infection in macaques.
ANTIBODIES TO CERAMIDE MONOHEXOSIDES AS POTENTIAL TOOLS FOR THE TREATMENT OF OPPORTUNISTIC MYCOSES.
Antibodies to CMV in patients with retinitis and colitis: a case-control study.
Antibodies to endogenous interferon alpha in controls and HIV infected persons in different disease states.
Antibodies to GP41 and nef in a male homosexual with Kaposi's sarcoma who is seronegative for HIV by conventional testing.
Antibodies to gp41 peptide (HIVIS, aa 583-599) do not correlate significantly with protection from disease in HIV infection.
Antibodies to HIV can be detected in air-dried saliva.
Antibodies to HIV p27 nef protein in 63 Zairian HIV seroconverters.
Antibodies to HIV reverse transcriptase as prognostic factors.
Antibodies to HIV-1 and HTLV-1 in Haiti.
Antibodies to HIV-1 gp 120 env epitopes correlate with uninfected status of the children born to seropositive mothers.
Antibodies to HIV-1 in passive immunotherapy (recipients and donors).
Antibodies to HIV-1 nef (P27) on the different stages of HIV infection.
Antibodies to HIV-1 nef and vif recombinant proteins in virus infected and risk group individuals.
Antibodies to HPV 16-E7 protein in patients with AIDS-Kaposi's sarcoma.
Antibodies to human immunodeficiency virus in seroconverters with a rapid test.
Antibodies to M. genitalium in patients with AIDS and patients attending sexual transmitted diseases clinics.
Antibodies to M. tuberculosis antigens in HIV-1 infected individuals.
Antibodies to P17, and its correlation with other serological markers during HIV-1 infection.
Antibodies to pneumocystis carinii. Reduced levels in HIV infected patients during pneumocystis infection and evaluation of passive immunisation.
Antibodies to SIV envelope peptides: their role in vaccine-induced protection.